- Transarterial chemoembolization versus resection for intermediate-stage (BCLC B) hepatocellular carcinoma
-
Kim JY, Sinn DH, Gwak GY, Choi GS, Saleh AM, Joh JW, Cho SK, Shin SW, Carriere K, Ahn JH, Paik YH, Choi MS, Lee JH, Koh KC, Paik SW
- KMID: 2373121
- Clin Mol Hepatol.
- 2016 Jun;22(2):250-258.
- doi: 10.3350/cmh.2016.0015
BACKGROUND/AIMS: Several studies have suggested that surgical resection (SR) can provide a survival benefit over transarterial chemoembolization (TACE) for hepatocellular carcinoma (HCC) at the intermediate stage according to the Barcelona... -
- CITED
-
- Close
- SHARE
-
- Close
